|
UBE2V2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.12951878353351E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.10970121980358E-11 |
| Normal-vs-Stage2 |
5.70850000047862E-07 |
| Normal-vs-Stage3 |
3.71370045826325E-10 |
| Normal-vs-Stage4 |
1.83186799063151E-12 |
| Stage1-vs-Stage2 |
9.800600E-01 |
| Stage1-vs-Stage3 |
6.788600E-01 |
| Stage1-vs-Stage4 |
1.408170E-02 |
| Stage2-vs-Stage3 |
8.075000E-01 |
| Stage2-vs-Stage4 |
6.629500E-02 |
| Stage3-vs-Stage4 |
5.096500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.9960036108132E-14 |
| Normal-vs-AfricanAmerican |
3.703900E-03 |
| Normal-vs-Asian |
3.87919999456088E-08 |
| Caucasian-vs-AfricanAmerican |
6.962200E-02 |
| Caucasian-vs-Asian |
7.836600E-01 |
| AfricanAmerican-vs-Asian |
1.974210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22377671832419E-13 |
| Normal-vs-Female |
2.6529001218023E-11 |
| Male-vs-Female |
3.766000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.32850438719856E-11 |
| Normal-vs-Age(41-60Yrs) |
1.56950008545209E-11 |
| Normal-vs-Age(61-80Yrs) |
1.4304000206522E-09 |
| Normal-vs-Age(81-100Yrs) |
3.591900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.686800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.480400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.716800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.732000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.203400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.619600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.096200E-01 |
| Classical-VS-Follicular |
8.651000E-01 |
| Classical-VS-Other |
9.335800E-02 |
| Classical-VS-Normal |
8.27626855937069E-12 |
| Tall-VS-Follicular |
1.901800E-01 |
| Tall-VS-Other |
2.714200E-01 |
| Tall-VS-Normal |
1.02310000471562E-08 |
| Follicular-VS-Other |
1.704570E-01 |
| Follicular-VS-Normal |
6.41980000049003E-07 |
| Other-VS-Normal |
4.46020000000047E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.06339953404233E-10 |
| Normal-vs-N1 |
9.31690280481234E-11 |
| N0-vs-N1 |
1.073980E-01 |
|
|
